Exosomes and Exosome-Mimetics for Atopic Dermatitis Therapy

被引:3
作者
Kim, Jae Hoon [1 ]
Kim, Ju-El [1 ]
Kang, Seong-Jun [1 ]
Yoon, Jeong-Kee [1 ]
机构
[1] Chung Ang Univ, Dept Syst Biotechnol, Anseong 17546, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
Atopic dermatitis; Exosome; Skin barrier; MESENCHYMAL STEM-CELLS; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR VESICLES; IN-VITRO; SKIN; NANOVESICLES; MECHANISMS; PROLIFERATION; ANGIOGENESIS; FIBROBLASTS;
D O I
10.1007/s13770-024-00695-5
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background:Exosomes and exosome mimetics are used as alternatives to cell therapy. They have shown potential in treating skin disorders by fortifying the skin barrier, mediating angiogenesis, and regulating the immune response while minimizing side effects. Currently, numerous studies have applied exosome therapy to treat atopic dermatitis (AD) caused by a weakened skin barrier and chronic inflammation. Research on exosomes and exosome mimetics represents a promising avenue for tissue regeneration, potentially paving the way for new therapeutic options. However, the efficacy of the therapy remains poorly understood. Also, the potential of exosome mimetics as alternatives to exosomes in skin therapy remains underexplored.Methods:Here, we reviewed the pathological features and current therapies of AD. Next, we reviewed the application of exosomes and exosome mimetics in regenerative medicine. Finally, we highlighted the therapeutic effects of exosomes based on their cell source and assessed whether exosome mimetics are viable alternatives.Results and conclusion:Exosome therapy may treat AD due to its skin regenerative properties, and exosome mimetics may offer an equally effective yet more efficient alternative. Research on exosomes and exosome mimetics represents a promising avenue for tissue regeneration, potentially paving the way for new therapeutic options.
引用
收藏
页码:381 / 396
页数:16
相关论文
共 121 条
[1]   Exosome: A New Player in Translational Nanomedicine [J].
Aheget, Houssam ;
Tristan-Manzano, Maria ;
Mazini, Loubna ;
Cortijo-Gutierrez, Marina ;
Galindo-Moreno, Pablo ;
Herrera, Concha ;
Martin, Francisco ;
Antonio Marchal, Juan ;
Benabdellah, Karim .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) :1-27
[2]   Topical glucocorticoids and the skin-mechanisms of action: an update [J].
Ahluwalia, A .
MEDIATORS OF INFLAMMATION, 1998, 7 (03) :183-193
[3]   The effect of multistrain synbiotic and vitamin D3 supplements on the severity of atopic dermatitis among infants under 1 year of age: a double-blind, randomized clinical trial study [J].
Aldaghi, Mitra ;
Tehrani, Human ;
Karrabi, Maryam ;
Abadi, Fatemeh Sham ;
Sahebkar, Mohammad .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) :812-817
[4]   The role of topical calcineurin inhibitors in atopic dermatitis [J].
Alomar, A ;
Berth-Jones, J ;
Bos, JD ;
Giannetti, A ;
Reitamo, S ;
Ruzicka, T ;
Stalder, JF ;
Thestrup-Pedersen, K .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 :3-27
[5]   Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery [J].
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Marazioti, Antonia .
PHARMACEUTICS, 2018, 10 (04)
[6]  
Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137
[7]   Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil [J].
Benez, A ;
Fierlbeck, G .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (03) :638-639
[8]   Mechanisms of disease: Atopic dermatitis [J].
Bieber, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) :1483-1494
[9]   Introduction to Stem Cell Therapy [J].
Biehl, Jesse K. ;
Russell, Brenda .
JOURNAL OF CARDIOVASCULAR NURSING, 2009, 24 (02) :98-103
[10]   Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles [J].
Boriachek, Kseniia ;
Islam, Md. Nazmul ;
Moller, Andreas ;
Salomon, Carlos ;
Nam-Trung Nguyen ;
Hossain, Md. Shahriar A. ;
Yamauchi, Yusuke ;
Shiddiky, Muhammad J. A. .
SMALL, 2018, 14 (06)